about
Invariant NKT cells as novel targets for immunotherapy in solid tumorsThe dual role of complement in cancer and its implication in anti-tumor therapyDoes an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?Antitumor Responses of Invariant Natural Killer T CellsImmunology of hepatocellular carcinomaControl of intestinal homeostasis through crosstalk between natural killer T cells and the intestinal microbiotaRole of non-conventional T lymphocytes in respiratory infections: the case of the pneumococcusA comprehensive ex vivo functional analysis of human NKT cells reveals production of MIP1-α and MIP1-β, a lack of IL-17, and a Th1-bias in malesA novel self-lipid antigen targets human T cells against CD1c(+) leukemiasCD1d-expressing breast cancer cells modulate NKT cell-mediated antitumor immunity in a murine model of breast cancer metastasis.Altered development of NKT cells, γδ T cells, CD8 T cells and NK cells in a PLZF deficient patient.Lipid antigens in immunity.iNKT cells suppress the CD8+ T cell response to a murine Burkitt's-like B cell lymphomaRole of Innate T Cells in Anti-Bacterial Immunity.Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+CD11b(high)Gr1(low) macrophages.Commensal microbiota and NKT cells in the control of inflammatory diseases at mucosal surfaces.Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammationDeveloping understanding of the roles of CD1d-restricted T cell subsets in cancer: reversing tumor-induced defects.Genomic modeling of tumor onset and progression in a mouse model of aggressive human liver cancer.Synthesis and Biological Activities of 5-Thio-α-GalCers.Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete RemissionsIL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity.Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humansA novel function of adipocytes in lipid antigen presentation to iNKT cells.NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma.Immune-based Therapy Clinical Trials in Hepatocellular CarcinomaUp-regulation of proliferative and migratory genes in regulatory T cells from patients with metastatic castration-resistant prostate cancer.Invariant natural killer T (iNKT) cell exhaustion in sarcoidosis.The polarization of immune cells in the tumour environment by TGFbeta.Fallen angels or risen apes? A tale of the intricate complexities of imbalanced immune responses in the pathogenesis and progression of immune-mediated and viral cancers.Glucose metabolism disorders and the risk of cancer.Primary immunodeficiency associated with defects in CD1 and CD1-restricted T cells.Immunomodulatory type II natural killer T lymphocytes in health and disease.The dual role of inflammation in colon carcinogenesisRole of type 1 natural killer T cells in pulmonary immunity.Immunosuppressive roles of natural killer T (NKT) cells in the skin.Protective role of NKT cells and macrophage M2-driven phenotype in bleomycin-induced pulmonary fibrosis.Natural Killer T cell subsets in eutopic and ectopic endometrium: a fresh look to a busy corner.Invariant natural killer T cells in hematopoietic stem cell transplantation: killer choice for natural suppression.Design, synthesis, and functional activity of labeled CD1d glycolipid agonists.
P2860
Q21284987-F1B6C736-8E1D-4CA2-84DA-0E82EDEF49A1Q26738682-A1154A61-4C52-4ECE-AF71-A81ECD6FBEE0Q26768699-15412A80-F807-4B9D-A209-A3CEC38757C2Q26778648-2ECD805B-A3F5-4A85-8A89-C516534D9835Q26795411-B0C14935-8EB6-4067-AC76-5E4B898D644CQ26825320-CB8F82F9-C511-4ECA-94B1-CC0C168ABCAEQ27026700-E4064380-6CF2-4CF1-979D-B28986ABC66BQ33748552-6EFFFC0D-CF9B-47F8-B4C6-88EC37881FAAQ33826848-59E8F2F3-0C8A-45A1-AA19-B6B7B384E864Q33939552-51C87B3C-07F8-4CA7-8834-B1E99535E7D9Q34019039-73439219-A660-4A59-8329-1724A1CCCF35Q34025822-5B47F1B7-6C3A-41EF-ABA4-8CE2F06A0CDEQ34374466-1F0A185A-2CB8-4EDC-BE04-A4AFA081AF35Q34482936-1705A70A-E5E5-4A5B-81D1-73A4B9700076Q34876594-35FB0E68-7211-4885-AFE2-AC88A27078E0Q35037683-CFD6D14A-6787-4BDB-823F-C46F2A49AC1FQ35103549-EA418E0C-CDED-4565-90D3-93102C0C667EQ35127172-45539B97-BEA8-45F0-89F5-EBC35C0A35B5Q35230309-63F0BAD5-8961-408C-806F-3766D0CCD3C0Q35559790-B9EB91F1-7CD2-4CDC-9982-C41D8B6711A6Q35958252-5F6E3ECF-71ED-48B5-B705-C3AD1A71AEF6Q36005345-0C49F5A9-E627-4D85-A6D5-1E38B5E71FDDQ36239694-6B665F71-A920-47E4-A6A2-F9A3902A1E38Q36559670-23D90A65-15E1-4587-8DC1-B72894945AE6Q36568780-AF012C23-3532-47E7-AD93-947DD5A90265Q36571270-26B1E344-B969-41DA-B336-C4706D9BD240Q36964048-384D46AB-48A8-408F-AB7C-19B62C836CFEQ37406517-3726D0D7-D99B-4BE6-943D-13BF2A230E38Q37454364-6F948E5E-AC07-4E1C-B41B-634B9BEDE9E2Q37620568-05BE5C84-03E7-4404-8342-7619F529F9C4Q37859317-CC703EA3-B6A5-429E-A42F-A153B5C46719Q37978654-6A4F2914-59BA-40B2-900A-7B9A9C1070A9Q38020906-CD287606-358C-4085-B8BC-23AD00AF6A75Q38056490-B0E026C3-548C-4069-A01B-D3074DEF065FQ38150638-94F6459C-6095-4757-9FD4-4189427FDBFEQ38209646-CC17BE06-6894-4E09-86F8-DD9C2EA52F54Q38639439-3D2A74CF-8EAC-41AB-AD08-DA2881E498B9Q38688814-AA8E6E1E-6737-4034-AD04-8FC8EF70F7D1Q38734173-34F37EF3-084B-4F7B-BA79-7D5B8A09D8FCQ39955940-73D80150-619D-4A6C-B595-48E779E422FB
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The contrasting roles of NKT cells in tumor immunity.
@en
The contrasting roles of NKT cells in tumor immunity.
@nl
type
label
The contrasting roles of NKT cells in tumor immunity.
@en
The contrasting roles of NKT cells in tumor immunity.
@nl
prefLabel
The contrasting roles of NKT cells in tumor immunity.
@en
The contrasting roles of NKT cells in tumor immunity.
@nl
P2860
P1476
The contrasting roles of NKT cells in tumor immunity.
@en
P2093
Jay A Berzofsky
Masaki Terabe
P2860
P304
P356
10.2174/156652409788970706
P577
2009-08-01T00:00:00Z